CHADDS FORD, PA -- (MARKET WIRE) -- February 22, 2007 -- Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP), a specialty pharmaceutical company with market leadership in pain management, today reported financial results for the fourth quarter and full year ended December 31, 2006.
